189 related articles for article (PubMed ID: 34069309)
1. Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia.
Kamijo T; Kaido T; Yoda M; Arai S; Yamauchi K; Okumura N
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069309
[TBL] [Abstract][Full Text] [Related]
2. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
[TBL] [Abstract][Full Text] [Related]
4. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
6. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
7. Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.
Yoda M; Kaido T; Kamijo T; Taira C; Higuchi Y; Arai S; Okumura N
Int J Hematol; 2021 Sep; 114(3):325-333. PubMed ID: 34117991
[TBL] [Abstract][Full Text] [Related]
8. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
[TBL] [Abstract][Full Text] [Related]
9. [Assembly and secretion of mutant fibrinogens with variant gamma-chain C terminal region (gamma313-gamma345)].
Terasawa F; Kamijyo Y; Fujihara N; Okumura N
Rinsho Byori; 2010 Aug; 58(8):772-8. PubMed ID: 20860169
[TBL] [Abstract][Full Text] [Related]
10. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A.
Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N
Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696
[TBL] [Abstract][Full Text] [Related]
11. A Novel Amino Acid Substitution, Fibrinogen Bβp.Pro234Leu, Associated with Hypofibrinogenemia Causing Impairment of Fibrinogen Assembly and Secretion.
Kaido T; Yoda M; Kamijo T; Arai S; Taira C; Higuchi Y; Okumura N
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322044
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
13. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
[TBL] [Abstract][Full Text] [Related]
14. A novel fibrinogen variant (fibrinogen Seoul II; AalphaGln328Pro) characterized by impaired fibrin alpha-chain cross-linking.
Park R; Doh HJ; An SS; Choi JR; Chung KH; Song KS
Blood; 2006 Sep; 108(6):1919-24. PubMed ID: 16735602
[TBL] [Abstract][Full Text] [Related]
15. Two novel mutations in the fibrinogen γ nodule.
Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
[TBL] [Abstract][Full Text] [Related]
16. Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma 275C, gamma 275H, and gamma 275A.
Hirota-Kawadobora M; Terasawa F; Suzuki T; Tozuka M; Sano K; Okumura N
J Thromb Haemost; 2004 Aug; 2(8):1359-67. PubMed ID: 15304042
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of fibrinogen synthesis and secretion between novel variant fibrinogen, nagakute (gamma305Thr --> Ala), and other variants located in gamma305-308 residues].
Kobayashi T; Takezawa Y; Terasawa F; Okumura N
Rinsho Byori; 2012 Sep; 60(9):831-8. PubMed ID: 23157111
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation.
de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW
Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
Bolliger-Stucki B; Lord ST; Furlan M
Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
[TBL] [Abstract][Full Text] [Related]
20. Evidence that heterodimers exist in the fibrinogen Matsumoto II (gamma308N-->K) proband and participate in fibrin fiber formation.
Okumura N; Terasawa F; Fujita K; Fujihara N; Tozuka M; Koh CS
Thromb Res; 2002 Aug; 107(3-4):157-62. PubMed ID: 12431483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
